Clinical trials
Hypercholesterolemia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
123 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 7 |
| 2010 | 2 |
| 2011 | 10 |
| 2012 | 17 |
| 2013 | 17 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 9 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
| Terminated | 7 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 22 |
| Sanofi | 12 |
| University of Manitoba | 9 |
| Regeneron Pharmaceuticals | 7 |
| Takeda | 5 |
| University of Toronto | 5 |
| Kastle Therapeutics, LLC | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Unity Health Toronto | 4 |
| Esperion Therapeutics, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 123 |
| Hyperlipidemias | 26 |
| Cardiovascular Diseases | 17 |
| Dyslipidemias | 13 |
| Hyperlipoproteinemia Type II | 13 |
| Diabetes Mellitus | 10 |
| Homozygous Familial Hypercholesterolemia | 8 |
| Diabetes Mellitus, Type 2 | 7 |
| Hypertension | 7 |
| Atherosclerosis | 6 |
Trials
Showing 26 to 50 of 123. Each trial links to its page on Pharma Observatory.
23 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.